About this trial
This clinical trial compares two different prehabilitation programs, with no organized prehabilitation, prior to major colorectal cancer surgery. The prehabilitation programs include intensive and coached physical exercise and optimized nutritional intake coupled with smoking cessation, physiological support and correction of poly-pharmacy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Planned for major gastrointestinal cancer surgery
Fluent in Norwegian and able to consent and to understand questionnaires
Disqualifiers
Inability to walk for six minutes or to rise independently from a chair
Inability to comprehend exercise program or to comply with written and oral instructions
Presence of a cardio-pulmonary condition that precludes exercise
Living in very remote areas making a hospital-based intervention group impossible to implement
Trial design
Parallel
Treatments tested in this trial
Prehabilitation
Other intervention* Nutritional optimization: A nutritionist will perform a structured interview, comprehensive nutrition assessment, and provide personalized dietary advice. The main goal is to ensure optimal protein intake to support exercise-induced anabolism. A daily protein intake of 1.2-2.0 g/kg will meet needs as outlined in surgical nutrition guidelines. * Exercise: Based on current guidelines and instructed by a dedicated physiotherapist, for 1 hour per day preoperatively to increase muscle strength, aerobic capacity and physical endurance. Intensity will be based on the rate of perceived exertion using the Borg scale, a 15-graded scale ranging from very light to very hard. Resistance exercises will target upper/lower body, and abdominal muscles. * Psychological coaching and support: Performed as one interview during inclusion, followed by weekly phone calls by a study nurse coordinator during the preoperative intervention.
Treatment groups
Trial outcomes
Primary outcomes
6MWT
Distance (in meters) walked in 6 minutes
Secondary outcomes
EuroQol Group Questionnaire 5D (EQ-5D)
EQ-5D is a standardized measure of health-related quality of life with 5 dimensions, each dimension represented by a value 1-5 where higher value represents worse outcome.
European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire
The EORTC Core Quality of Life questionnaire (EORTC QLQ-C30) is designed to measure cancer patients' physical, psychological and social functions. The questionnaire range from 0 to 100; a higher score represents a higher ("better") level of functioning, or a higher ("worse") level of symptoms.
Generic Short Patient Experiences Questionnaire (GS-PEQ)
GS-PEQ is a questionnaire for collecting data about user experiences across different types of services. The questionnaire has 12 questions ranging from 1-5; a higher score represents a higher ("better") experience.
Mortality
90-day mortality
Other outcomes
DNA methylation
Blood samples for DNA methylation profiling will be implemented in a machine learning algorithm to search for biomarkers reliably reflecting frailty and effect of prehabilitation.
RNA methylation
Blood samples for RNA methylation profiling will be implemented in a machine learning algorithm to search for biomarkers reliably reflecting frailty and effect of prehabilitation.
Metabolome
Blood samples for metabolome profiling will be implemented in a machine learning algorithm to search for biomarkers reliably reflecting frailty and effect of prehabilitation.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Vestre Viken Hospital Trust
Lead sponsor
Diakonhjemmet Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options: